X
Bayer bolsters R&D platform with $2bn Vividion takeover
https://pharmaphorum.com/news/bayer-bolsters-rd-platform-with-2bn-vividion-takeover/
Vividion
Celgene to tackle ‘undruggable’ targets with Vividion
Celgene has signed a deal with Vividion Therapeutics to develop drugs for oncology, inflammatory, and neurodegenerative diseases.